Extra COVID-19 dose: Study finds 2023 booster boosted immune defense over last year’s shots

A recent study sheds light on the potential benefits of COVID-19 booster shots administered last year in shaping immune responses against the virus and its early variants. The research, led by experts at the University of Washington School of Medicine, highlights the importance of expanding vaccination rates to fight the pandemic.

The study, led by biochemist David Veesler, tested how repeated exposures to COVID-19 vaccines influenced the body’s immune reaction to subsequent infections. Known as immune fingerprinting, this procedure involves the creation of antibodies and memory cells that retain data about past exposures to a vaccine or virus.

Unlike what is seen with other viruses such as influenza, where the fingerprint decreases after exposure to other strains, they found a noticeable appearance of immune fingerprints in reaction to the COVID-19 pandemic. This imprint gave the immune formula a starting point in the fight. of future infections.

Published in the journal Immunity, a monthly peer-reviewed immunology medical journal, on March 14, the results analyzed plasma samples from other people who received the XBB. 1. 5 mRNA booster last year, not updated versions of the vaccines. Dr. Alejandra Tortorici and Dr. Helen Chu of the Division of Allergy and Infectious Diseases were among the study participants.

Seattle reported the first death from the COVID-19 pandemic in the U. S. And symptoms of the virus began in early 2020.

Another option suggested by the researchers is that the strong immune reaction induced by the mRNA vaccines, combined with delays in updating booster compositions, would possibly have influenced the fingerprinting process.

The study highlights the importance of vaccination efforts and ongoing studies to combat COVID-19 and its variants well. Veesler highlighted the possibility of even more potent immune responses, saying, “Most of the antibodies recalled from the market during the most recent vaccine boosters are cross-reactive. “and help block new variants, which is a smart thing to do. However, can we do even more work? The answer is probably yes.

Funding for the study was provided through a variety of sources, including the National Institutes of Health, the National Institute of Allergy and Infectious Diseases, the Pew Biomedical Scholars Award, Washington Arnold University, and the Mabel Beckman Cryo-EM Center.

Learn more about the latest COVID-19 vaccination tips on the Washington State Department of Health website.

Made imaginable into component through the Washington State Health Breakdown through a grant from the Centers for Disease Control and Prevention. These data do not necessarily reflect the official policies of the Washington State Health Component or the Health and Human Services Component.

         

Leave a Comment

Your email address will not be published. Required fields are marked *